HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC.
Funaishi K, Yamaguchi K, Tanahashi H, Kurose K, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Iwamoto H, Hamada H, Oga T, Oka M, Hattori N.
Funaishi K, et al. Among authors: sakamoto s.
Cancer Chemother Pharmacol. 2025 Jan 24;95(1):28. doi: 10.1007/s00280-025-04751-2.
Cancer Chemother Pharmacol. 2025.
PMID: 39853458
Free PMC article.